| Project/Area Number |
17590050
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | HOKKAIDO UNIVERSITY |
|---|
Principal Investigator |
UEHARA Takashi Hokkaido Univ., Fac. Pharmaceu. Sci., Associate Prof., 大学院薬学研究院, 助教授 (00261321)
|
|---|
| Project Period (FY) |
2005 – 2006
|
| Project Status |
Completed (Fiscal Year 2006)
|
| Budget Amount *help |
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2006: ¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 2005: ¥1,800,000 (Direct Cost: ¥1,800,000)
|
|---|
| Keywords | nitric oxide / ER stress / S-nitrosylation / protein-disulfide isomerase / apoptosis / neurodegeneration / Parkinson's disease / brain ischemia / PDI |
|---|
| Research Abstract |
Stress proteins located in the cytosol or endoplasmic reticulum (ER) participate in maintenance of cell homeostasis and development of tolerance against severe insults. In neurodegenerative diseases, a number of chaperones can ameliorate accumulation of misfolded proteins triggered by oxidative/nitrosative stress or mutated gene products. Here we show that one such ER chaperone, protein-disulfide isomerase (PDI), is S-nitrosylated in brains manifesting sporadic Parkinson's or Alzheimer's disease. Nitric oxide-induced S-nitrosylation of PDI inhibits its enzymatic activity, leads to accumulation of polyubiquitinated proteins, and activates the unfolded protein response (UPR). S-Nitrosylation also abrogates PDI-mediated attenuation of neuronal cell death triggered by ER stress or proteasome inhibition. Thus, PDI prevents neurotoxicity associated with ER stress and protein misfolding, but nitric oxide blocks this protective effect in neurodegenerative disorders via PDI S-nitrosylation.
|
